Inotiv, Inc.
Inotiv, Inc. (NOTV) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Inotiv, Inc. (NOTV), covering cash flow, earnings, and balance sheets.
Inotiv, Inc. (NOTV) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Inotiv, Inc. NOTV financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $124.32M | $119.88M | $130.42M | $105.79M |
| Cost of Revenue | $95.33M | $94.84M | $100.48M | $84.70M |
| Gross Profit | $28.99M | $25.04M | $29.94M | $21.08M |
| Gross Profit Ratio | $0.23 | $0.21 | $0.23 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $22.23M | $24.29M | $25.63M | $21.81M |
| Operating Expenses | $31.93M | $40.55M | $43.11M | $41.83M |
| Total Costs & Expenses | $127.26M | $135.38M | $143.58M | $126.54M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $13.45M | $13.84M | $12.32M | $12.12M |
| Depreciation & Amortization | $13.82M | $14.18M | $14.59M | $14.12M |
| EBITDA | $11.29M | -$1.79M | $2.87M | -$6.71M |
| EBITDA Ratio | $0.09 | -$0.01 | $0.02 | -$0.06 |
| Operating Income | -$2.94M | -$15.51M | -$13.17M | -$20.75M |
| Operating Income Ratio | -$0.02 | -$0.13 | -$0.10 | -$0.20 |
| Other Income/Expenses (Net) | -$13.04M | -$14.30M | -$10.88M | -$12.20M |
| Income Before Tax | -$15.98M | -$29.81M | -$24.05M | -$32.95M |
| Income Before Tax Ratio | -$0.13 | -$0.25 | -$0.18 | -$0.31 |
| Income Tax Expense | $1.11M | -$2.18M | -$5.15M | -$6.86M |
| Net Income | -$14.87M | -$27.63M | -$18.89M | -$26.09M |
| Net Income Ratio | -$0.12 | -$0.23 | -$0.14 | -$0.25 |
| EPS | -$0.44 | -$1.02 | $3.44 | -$1.00 |
| Diluted EPS | -$0.44 | -$1.02 | $3.44 | -$1.00 |
| Weighted Avg Shares Outstanding | $33.99M | $27.16M | $26.001M | $25.99M |
| Weighted Avg Shares Outstanding (Diluted) | $33.99M | $27.16M | $26.001M | $25.99M |
Over the past four quarters, Inotiv, Inc. demonstrated steady revenue growth, increasing from $105.79M in Q3 2024 to $124.32M in Q2 2025. Operating income reached -$2.94M in Q2 2025, maintaining a consistent -2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $11.29M, reflecting operational efficiency. Net income rose to -$14.87M, with EPS at -$0.44. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan